Aankondiging • May 15
Linde India Limited to Report Q4, 2026 Results on May 30, 2026 Linde India Limited announced that they will report Q4, 2026 results at 9:15 AM, Indian Standard Time on May 30, 2026 Reported Earnings • Feb 11
Third quarter 2026 earnings released: EPS: ₹22.67 (vs ₹13.64 in 3Q 2025) Third quarter 2026 results: EPS: ₹22.67 (up from ₹13.64 in 3Q 2025). Revenue: ₹7.05b (up 16% from 3Q 2025). Net income: ₹1.93b (up 66% from 3Q 2025). Profit margin: 27% (up from 19% in 3Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 21% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Feb 02
Linde India Limited to Report Q3, 2026 Results on Feb 09, 2026 Linde India Limited announced that they will report Q3, 2026 results on Feb 09, 2026 Reported Earnings • Nov 07
Second quarter 2026 earnings released: EPS: ₹20.05 (vs ₹12.48 in 2Q 2025) Second quarter 2026 results: EPS: ₹20.05 (up from ₹12.48 in 2Q 2025). Revenue: ₹6.48b (up 2.1% from 2Q 2025). Net income: ₹1.71b (up 61% from 2Q 2025). Profit margin: 26% (up from 17% in 2Q 2025). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Oct 27
Linde India Limited to Report Q2, 2026 Results on Nov 06, 2025 Linde India Limited announced that they will report Q2, 2026 results on Nov 06, 2025 Upcoming Dividend • Jul 31
Upcoming dividend of ₹12.00 per share Eligible shareholders must have bought the stock before 07 August 2025. Payment date: 13 September 2025. Payout ratio is a comfortable 8.4% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%). Aankondiging • Jul 25
Linde India Limited to Report Q1, 2026 Results on Aug 07, 2025 Linde India Limited announced that they will report Q1, 2026 results on Aug 07, 2025 Reported Earnings • Jul 23
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: ₹53.33 (up from ₹50.90 in FY 2024). Revenue: ₹24.9b (down 10% from FY 2024). Net income: ₹4.55b (up 4.8% from FY 2024). Profit margin: 18% (up from 16% in FY 2024). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 7.0%. Earnings per share (EPS) also missed analyst estimates by 1.0%. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • May 26
Linde India Limited, Annual General Meeting, Aug 14, 2025 Linde India Limited, Annual General Meeting, Aug 14, 2025. Declared Dividend • May 25
Dividend of ₹12.00 announced Shareholders will receive a dividend of ₹12.00. Ex-date: 7th August 2025 Payment date: 13th September 2025 Dividend yield will be 0.2%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (8% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 23% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 80% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • May 24
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: ₹53.33 (up from ₹50.90 in FY 2024). Revenue: ₹25.5b (down 7.8% from FY 2024). Net income: ₹4.55b (up 4.8% from FY 2024). Profit margin: 18% (up from 16% in FY 2024). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 7.0%. Earnings per share (EPS) also missed analyst estimates by 1.0%. Revenue is forecast to grow 33% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • May 16
Linde India Limited to Report Q4, 2025 Results on May 23, 2025 Linde India Limited announced that they will report Q4, 2025 results on May 23, 2025 Price Target Changed • Feb 11
Price target decreased by 8.7% to ₹7,206 Down from ₹7,890, the current price target is an average from 2 analysts. New target price is 21% above last closing price of ₹5,951. Stock is up 8.6% over the past year. The company is forecast to post earnings per share of ₹53.87 for next year compared to ₹50.90 last year. Reported Earnings • Feb 08
Third quarter 2025 earnings released: EPS: ₹13.64 (vs ₹14.08 in 3Q 2024) Third quarter 2025 results: EPS: ₹13.64 (down from ₹14.08 in 3Q 2024). Revenue: ₹6.25b (down 12% from 3Q 2024). Net income: ₹1.16b (down 3.1% from 3Q 2024). Profit margin: 19% (up from 17% in 3Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 35% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Jan 28
Linde India Limited to Report Q3, 2025 Results on Feb 07, 2025 Linde India Limited announced that they will report Q3, 2025 results on Feb 07, 2025 Board Change • Nov 14
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Non-Executive Independent Director Shalini Sarin was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 08
Second quarter 2025 earnings released: EPS: ₹12.48 (vs ₹12.75 in 2Q 2024) Second quarter 2025 results: EPS: ₹12.48 (down from ₹12.75 in 2Q 2024). Revenue: ₹6.51b (down 8.5% from 2Q 2024). Net income: ₹1.06b (down 2.1% from 2Q 2024). Profit margin: 16% (up from 15% in 2Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 43% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Oct 29
Linde India Limited to Report Q2, 2025 Results on Nov 07, 2024 Linde India Limited announced that they will report Q2, 2025 results on Nov 07, 2024 Aankondiging • Sep 24
Linde India Limited Announces Resignation of Directors Linde India Limited announced that effective close of business hours on 30 September 2024, Mr. Arun Balakrishnan and Mr. Jyotin Kantilal Mehta, Independent Directors of the Company, shall retire from the Board upon completion of their respective second term of five consecutive years as Independent Directors. Price Target Changed • Aug 13
Price target increased by 8.0% to ₹8,541 Up from ₹7,909, the current price target is an average from 2 analysts. New target price is 15% above last closing price of ₹7,438. Stock is up 52% over the past year. The company is forecast to post earnings per share of ₹64.72 for next year compared to ₹50.90 last year. Reported Earnings • Aug 07
First quarter 2025 earnings released: EPS: ₹13.33 (vs ₹11.71 in 1Q 2024) First quarter 2025 results: EPS: ₹13.33 (up from ₹11.71 in 1Q 2024). Revenue: ₹6.72b (down 6.7% from 1Q 2024). Net income: ₹1.14b (up 14% from 1Q 2024). Profit margin: 17% (up from 14% in 1Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 63% per year, which means it is well ahead of earnings. Declared Dividend • Jul 30
Dividend of ₹12.00 announced Shareholders will receive a dividend of ₹12.00. Ex-date: 5th August 2024 Payment date: 11th September 2024 Dividend yield will be 0.2%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (8% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 23% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 124% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Aankondiging • Jul 29
Linde India Limited to Report Q1, 2025 Results on Aug 06, 2024 Linde India Limited announced that they will report Q1, 2025 results on Aug 06, 2024 Aankondiging • May 31
Linde India Limited, Annual General Meeting, Aug 12, 2024 Linde India Limited, Annual General Meeting, Aug 12, 2024. Aankondiging • May 19
Linde India Limited to Report Q4, 2024 Results on May 28, 2024 Linde India Limited announced that they will report Q4, 2024 results on May 28, 2024 Reported Earnings • Feb 06
Third quarter 2024 earnings released: EPS: ₹14.08 (vs ₹11.64 in 3Q 2023) Third quarter 2024 results: EPS: ₹14.08 (up from ₹11.64 in 3Q 2023). Revenue: ₹7.28b (up 16% from 3Q 2023). Net income: ₹1.20b (up 21% from 3Q 2023). Profit margin: 17% (in line with 3Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 76% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Jan 24
Linde India Limited to Report Q3, 2024 Results on Feb 05, 2024 Linde India Limited announced that they will report Q3, 2024 results on Feb 05, 2024 Price Target Changed • Jan 07
Price target increased by 8.3% to ₹6,819 Up from ₹6,299, the current price target is an average from 2 analysts. New target price is 22% above last closing price of ₹5,583. Stock is up 66% over the past year. The company is forecast to post earnings per share of ₹53.59 for next year compared to ₹55.35 last year. Reported Earnings • Nov 07
Second quarter 2024 earnings released: EPS: ₹12.75 (vs ₹10.66 in 2Q 2023) Second quarter 2024 results: EPS: ₹12.75 (up from ₹10.66 in 2Q 2023). Revenue: ₹7.30b (up 1.3% from 2Q 2023). Net income: ₹1.09b (up 20% from 2Q 2023). Profit margin: 15% (up from 13% in 2Q 2023). The increase in margin was primarily driven by lower expenses. Revenue is forecast to grow 34% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 93% per year, which means it is well ahead of earnings. Aankondiging • Oct 29
Linde India Limited to Report Q2, 2024 Results on Nov 06, 2023 Linde India Limited announced that they will report Q2, 2024 results on Nov 06, 2023 Price Target Changed • Aug 21
Price target increased by 14% to ₹5,539 Up from ₹4,861, the current price target is an average from 2 analysts. New target price is 5.5% above last closing price of ₹5,248. Stock is up 58% over the past year. The company is forecast to post earnings per share of ₹53.03 for next year compared to ₹55.35 last year. Aankondiging • Aug 18
Linde India Limited Approves Dividend for the 15 Months Period Ended March 31, 2023 Linde India Limited approved dividend of INR 12.00 per equity share for the 15 months period ended March 31, 2023 at its Annual General Meeting held on 17 Aug. 2023. Price Target Changed • Aug 15
Price target increased by 9.7% to ₹5,147 Up from ₹4,694, the current price target is an average from 2 analysts. New target price is 5.3% above last closing price of ₹4,887. Stock is up 45% over the past year. The company is forecast to post earnings per share of ₹54.44 for next year compared to ₹55.35 last year. Upcoming Dividend • Aug 03
Upcoming dividend of ₹12.00 per share at 0.2% yield Eligible shareholders must have bought the stock before 10 August 2023. Payment date: 16 September 2023. Payout ratio is a comfortable 6.5% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%). Aankondiging • Jul 29
Linde India Limited to Report Q1, 2024 Results on Aug 08, 2023 Linde India Limited announced that they will report Q1, 2024 results on Aug 08, 2023 Aankondiging • May 13
Linde India Limited to Report Q1, 2023 Results on May 23, 2023 Linde India Limited announced that they will report Q1, 2023 results on May 23, 2023 Aankondiging • Feb 16
Linde India Limited Approves the Appointment of Michael James Devine as an Additional Director (Non-Executive) of the Company Linde India Limited announced that the Board of Directors of the Company on recommendation of the Nomination and Remuneration Committee of the Board approved the appointment of Mr. Michael James Devine (DIN: 10042702) as an Additional Director (Non-Executive) of the Company with effect from 15 February 2023. Mr. Michael James Devine, aged about 54 years, has completed his Doctor of Jurisprudence from Creighton UniversitySchool of Law and a Bachelor of Arts in Economics. Mr. Devine is the Associate General Counsel of Linde Plc. and has hadan illustrious and accomplished career in handling several large corporate and commercial transactions in his career,including the merger of Praxair Inc. and Linde AG. Mr. Devine has earlier served as the Chief Transactions Counsel forLinde Plc. and for Praxair Inc. and is currently heading the M&A Legal Department for Linde Plc. Price Target Changed • Feb 15
Price target increased by 9.1% to ₹4,133 Up from ₹3,790, the current price target is provided by 1 analyst. New target price is 14% above last closing price of ₹3,622. Stock is up 37% over the past year. The company is forecast to post earnings per share of ₹50.24 for next year compared to ₹59.47 last year. Aankondiging • Feb 14
Linde India Limited Announces Executive Changes Linde India Limited announced that Mr. Robert John Hughes (DIN: 08493540) resigned from the Board as the Non-Executive Director and Chairman of the Company with effect from the close of business hours on 13 February 2023 in view of his other personal and professional commitments. The Board has accepted the resignation of Mr. Robert John Hughes as the Non-Executive Director and Chairman of the Company with effect from the aforesaid date. The Board is in the process of appointing an Additional Director in the vacancy caused due to the resignation of Mr. Hughes. The Board has noted that Mr. Pawan Marda, Director Corporate Affairs and Company Secretary of the Company will be superannuating from the services of Linde India Ltd. with effect from close of business hours on 28 February 2023 and will therefore cease to be the Key Managerial Personnel and Compliance Officer of the Company with effect from 1 March 2023. The Board has approved the appointment of Mr. Amit Dhanuka (Membership No. A 23872) as the Company Secretary (Key Managerial Personnel) of the Company with effect from 1 March 2023 on the recommendation of the Nomination and Remuneration Committee and Audit Committee of the Board of Directors of the Company. Mr. Amit Dhanuka will also take over the role of Compliance Officer of the Company pursuant to Regulation 6 of the SEBI Listing Regulations, 2015 with effect from the said date. Mr. Amit Dhanuka, aged about 37 years, is a qualified Company Secretary (Membership No. A23872) and a Bachelor of Commerce. Mr. Dhanuka has gathered rich experience of over 15 years in corporate secretarial functions dealing with company law related matters, SEBI Regulations, mergers and acquisitions, etc. in his earlier roles across various companies. Immediately before joining Linde India Ltd., Mr. Dhanuka was the Company Secretary of Xpro India Ltd. Aankondiging • Jan 31
Linde India Limited to Report Q4, 2022 Results on Feb 13, 2023 Linde India Limited announced that they will report Q4, 2022 results on Feb 13, 2023 Reported Earnings • Nov 17
Third quarter 2022 earnings released: EPS: ₹10.66 (vs ₹7.46 in 3Q 2021) Third quarter 2022 results: EPS: ₹10.66 (up from ₹7.46 in 3Q 2021). Net income: ₹909.4m (up 43% from 3Q 2021). Revenue is forecast to grow 40% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 70% per year, which means it is well ahead of earnings. Price Target Changed • Sep 19
Price target increased to ₹3,790 Up from ₹3,395, the current price target is provided by 1 analyst. New target price is 13% above last closing price of ₹3,357. Stock is up 31% over the past year. The company is forecast to post earnings per share of ₹51.58 for next year compared to ₹59.47 last year. Reported Earnings • Aug 13
Second quarter 2022 earnings released: EPS: ₹20.15 (vs ₹8.50 in 2Q 2021) Second quarter 2022 results: EPS: ₹20.15 (up from ₹8.50 in 2Q 2021). Revenue: ₹5.88b (up 13% from 2Q 2021). Net income: ₹1.72b (up 137% from 2Q 2021). Profit margin: 29% (up from 14% in 2Q 2021). The increase in margin was primarily driven by higher revenue. Over the next year, revenue is forecast to grow 20%, compared to a 14% growth forecast for the industry in India. Price Target Changed • Jun 03
Price target increased to ₹3,395 Up from ₹3,046, the current price target is provided by 1 analyst. New target price is 11% above last closing price of ₹3,051. Stock is up 90% over the past year. The company is forecast to post earnings per share of ₹46.40 for next year compared to ₹59.47 last year. Upcoming Dividend • May 25
Upcoming dividend of ₹13.50 per share Eligible shareholders must have bought the stock before 01 June 2022. Payment date: 23 July 2022. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.7%). Lower than average of industry peers (0.8%). Reported Earnings • May 15
First quarter 2022 earnings released: EPS: ₹7.74 (vs ₹35.56 in 1Q 2021) First quarter 2022 results: EPS: ₹7.74 (down from ₹35.56 in 1Q 2021). Revenue: ₹5.48b (up 24% from 1Q 2021). Net income: ₹659.8m (down 78% from 1Q 2021). Profit margin: 12% (down from 69% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 23%, compared to a 21% growth forecast for the industry in India. Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment improved over the past week After last week's 23% share price gain to ₹3,256, the stock trades at a forward P/E ratio of 63x. Average forward P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 567% over the past three years. Reported Earnings • Feb 27
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: ₹59.47 (up from ₹17.72 in FY 2020). Revenue: ₹21.7b (up 47% from FY 2020). Net income: ₹5.07b (up 236% from FY 2020). Profit margin: 23% (up from 10% in FY 2020). Revenue exceeded analyst estimates by 4.0%. Over the next year, revenue is forecast to grow 23%, compared to a 20% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 76% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Feb 21
Investor sentiment improved over the past week After last week's 15% share price gain to ₹2,971, the stock trades at a forward P/E ratio of 54x. Average forward P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 606% over the past three years. Price Target Changed • Nov 15
Price target increased to ₹3,046 Up from ₹2,007, the current price target is provided by 1 analyst. New target price is 21% above last closing price of ₹2,509. Stock is up 189% over the past year. The company posted earnings per share of ₹17.72 last year. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment improved over the past week After last week's 23% share price gain to ₹2,286, the stock trades at a forward P/E ratio of 46x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 475% over the past three years. Reported Earnings • Aug 13
Second quarter 2021 earnings released: EPS ₹8.50 (vs ₹2.32 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹5.19b (up 109% from 2Q 2020). Net income: ₹725.0m (up 266% from 2Q 2020). Profit margin: 14% (up from 8.0% in 2Q 2020). Price Target Changed • Aug 11
Price target increased to ₹2,067 Up from ₹1,923, the current price target is provided by 1 analyst. New target price is 17% above last closing price of ₹1,759. Stock is up 146% over the past year. Executive Departure • Jun 24
Additional Non-Executive Director Wei Chan has left the company On the 17th of June, Wei Chan's tenure as Additional Non-Executive Director ended after 1.6 years in the role. We don't have any record of a personal shareholding under Wei's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 2.00 years. Upcoming Dividend • Jun 09
Upcoming dividend of ₹3.00 per share Eligible shareholders must have bought the stock before 16 June 2021. Payment date: 24 July 2021. Trailing yield: 0.2%. Lower than top quartile of Indian dividend payers (1.6%). Lower than average of industry peers (0.7%). Reported Earnings • May 14
First quarter 2021 earnings released: EPS ₹35.56 (vs ₹4.58 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₹4.46b (up 18% from 1Q 2020). Net income: ₹3.03b (up ₹2.64b from 1Q 2020). Profit margin: 68% (up from 10% in 1Q 2020). Reported Earnings • Mar 03
Full year 2020 earnings released: EPS ₹17.72 (vs ₹85.27 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: ₹15.0b (down 15% from FY 2019). Net income: ₹1.51b (down 79% from FY 2019). Profit margin: 10.0% (down from 41% in FY 2019). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth. Analyst Estimate Surprise Post Earnings • Mar 03
Revenue beats expectations Revenue exceeded analyst estimates by 5.5%. Over the next year, revenue is forecast to grow 16%, compared to a 21% growth forecast for the Chemicals industry in India.